Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the DISCOVER study

Type 2 diabetes mellitus (T2D) is associated with microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (coronary heart disease, cerebrovascular disease and peripheral arterial disease) complications [1 –4]. Both T2D and its associated complications can reduce health-related quality of life (HRQoL) [5–7], which refers to an individual’s perception of physical, emotional and social functioning in relation to health status. Furthermore, diabetes is associated with depression and disease-related stress [8–10].

Source: Diabetes Research and Clinical Practice - July 21, 2021 Category: Endocrinology Authors: Antonio Nicolucci, Hungta Chen, Javier Cid-Ruzafa, Andrew Cooper, Peter Fenici, Marilia B Gomes, Niklas Hammar, Kamlesh Khunti, Mikhail Kosiborod, Paul Leigh, Jennie Medin, Wolfgang Rathmann, Marina V. Shestakova, Iichiro Shimomura, Afrah Siddiqui, Fengmi Source Type: research